@t3micro SinglePass Curl stays #1. InStyle Best Beauty Buys 2026 award winner. 🏆 Available in-store at Skin Deep. . . #Skindeep #T3micro #Curlingiron #Hair #Hairstyle

.@MetsoOfficial introduces the next generation of its #lithiumcarbonate production process, a proven #alkalineleach #singlepass tech to produce battery-grade lithium carbonate sustainably from #spodumene concentrate with high yield & low operating costs shorturl.at/Bzf0b

Just got the T3 Singlepass Curl X 1.25mm and I am so very very very pleaseddddd.

singlepass multipass mode is more than fine and saves on performance hits

Houdini ﾐﾆﾐﾆ tipsなんだけど、foreach の挙動を1個1個確認したいときにSinglePassに$Fっていれると確認しやすい

Hurry and Snag some Savings on this SinglePass Curl X Ceramic Extra-Long Barrel Curling Iron! shorturl.at/WWVj1 Sponsored

歴史を振り返ると、三井化学は2019年5月にASMとEUVペリクル事業に関するライセンス契約を締結し、生産権および販売権を取得した。その後、2021年5月26日にはEUVペリクルの商業生産開始を正式に発表した。これら初期の製品はポリSiコア構造のペリクルである。 　しかし、より高い透過率が求められる中で、三井化学はポリSiコアからCNTへの材料転換を決断した。図7に示された同社のRoadmapによれば（詳細は明示されていないものの）、2025年頃からCNTペリクルの開発・製造に本格着手したと推察される。 　今回発表されたCNTペリクルの性能は、図8にまとめられている。EUV光の単一透過（singlepass）での透過率は94％、3回透過と仮定した場合の透過率は約83％となる。また寿命は5000枚～1万枚で、20μm以上の異物はゼロと書かれている。

Have you heard about the latest technology in biopsy closure? SinglePass has teamed up with the @SIRspecialists to bring you this expert-led webinar that covers post-biopsy bleeding control and discusses the SinglePass biopsy closure device. Join us Dec 9 to learn more!

SinglePass Kronos electrocautery device for closure after percutaneous medical liver biopsy #some4surgery wjgnet.com/1007-9327/full/v3…

singlepass line my beloved

Wasmer can run Wasm via many engines: JSC being one of them! Wasmer supports running Wasm universally with: * Wasmer System compilers (Singlepass, Cranelift, LLVM) * V8 * JavascriptCore * Wasmi * WAMR * Your browser JS!

Count Elements With Maximum Frequency (Easy) Single-pass: track freq max count simultaneously Reset count on new max, accumulate on match. Real-time frequency tracking! #LeetCode #100DaysOfCode #Easy #SinglePass

Path tracing is also MUCH easier on CPU code is simple. I have basically 1 "draw call"/eye/frame. I can do 1 draw for 2 eyes in singlepass but perf is ~same, there are benefits to rendering one eye after the other (pipelining TLAS updates/rebuilds DLSS-RR) or for VR SLI.

I just received a contribution towards T3 SinglePass StyleMax Professional 1" Ceramic Flat Iron with Custom Heat Automation, 9 Heat Settings, Longer Ceramic Plates, For Straightening, Wavi from Trask via Throne. Thank you! throne.com/aspynthemermaid #Wishlist #Throne

An item on my Throne wishlist just got fully funded: T3 SinglePass StyleMax Professional 1" Ceramic Flat Iron with Custom Heat Automation, 9 Heat Settings, Longer Ceramic Plates, For Straightening, Waving, Curl. Thank you! throne.com/aspynthemermaid #Wishlist #Throne

VRだとなんか違和感あるなと思ったら オーロラが左目しか描画されない このページを参考にシェーダー修正したら右目も描画された redhologerbera.hatenablog.co… XRの設定でMultiPassにしても両目描画される SinglePassの方が負荷は低いのかな

$ADHC GlucoGuard partnership with Dexcom (NASDAQ: $DXCM), a giant industry leader trading at a $33B market cap Here’s GlucoGuard summary where Dexcom $DXCM is listed as the CGM developer glucoguardsleep.com/summary/ Also Bill Colone is on the ADHC/GlucoGuard team, he has an insane track record in the medical device field. He’s actually listed as Chairman of advisory board on the GlucoGuard website. Bill Colone is also the current CEO of SinglePass which recently got FDA clearance for their Kronos biopsy closure device last year. Bill actually navigated numerous companies through the FDA Approval process Bill Colone also helped position a surgical vascular graft product company IMPRA Inc which later was ACQUIRED by CR Bard for $143M Bill was Director of Operations of IMPRA for 11 years. Also Bill was the active CEO of Endomed when it was ACQUIRED by $LMAT LeMaitre Vascular, a $1.8B dollar company He had success and experience in the bio medical device field for over 30 years and he holds 13 US patents for medical devices with others pending. It’s crazy to see industry veterans this caliber on the team of a OTC traded company. Both Bill Colone and Stephen C. Weber are listed on the team on the GlucoGuard website here: glucoguardsleep.com/about-us… $ADHC GlucoGuard: Bill Colonel - Chairman of the Advisory Board Stephen C. Weber - Head of the Medical Advisory Board Zachary Smith - CEO Definitely keep an eye out on them

$ADHC added a former FDA official Dr. Stephen C. Weber on their advisory board Since then they already filed a Breakthrough Device application with the FDA for GlucoGuard and received favorable review mentioned in last weeks PR Its the only medical device designed to automatically deliver glucose when needed and reduce risks associated with hypoglycemia while you’re sleeping. Untreated hypoglycemia can lead to death. Other complications include: seizures, brain damage, coma, multi-organ failure and more. Diabetes is the eighth leading cause of death in the United States. The market for Diabetes medical devices is absolutely massive, approximately $30B annually. Around 422 million people worldwide have diabetes, and 1.5 Million deaths are directly attributed to diabetes each year. Also Bill Colone is on the ADHC/GlucoGuard team, he has an amazing track record in the medical device field. Bill Colone is also the current CEO of SinglePass which recently got FDA clearance in April for their Kronos biopsy closure device. Bill Colone also helped position a surgical vascular graft product company IMPRA Inc which later was ACQUIRED by CR Bard for $143M Bill was Director of Operations of IMPRA for 11 years. Also Bill was the active CEO of Endomed when it was ACQUIRED by $LMAT LeMaitre Vascular, a $2B dollar company He had success and experience in the bio medical device field for over 30 years and he holds 13 US patents for medical devices with others pending. It’s crazy to see industry veterans this caliber on the team of a OTC traded company. Both Bill Colone and Stephen C. Weber are listed on the team on the GlucoGuard website here: glucoguardsleep.com/about-us… Link to last weeks news (4/29/2025): American Diversified Holdings Corporation (ADHC) Receives Favorable FDA Review newsfilecorp.com/release/250…